Use of Metformin Alone Is Not Associated with Survival Outcomes of Colorectal Cancer Cell but AMPK Activator AICAR Sensitizes Anticancer Effect of 5-Fluorouracil through AMPK Activation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Use of Metformin Alone Is Not Associated with Survival Outcomes of Colorectal Cancer Cell but AMPK Activator AICAR Sensitizes Anticancer Effect of 5-Fluorouracil through AMPK Activation
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 5, Pages e97781
Publisher
Public Library of Science (PLoS)
Online
2014-05-22
DOI
10.1371/journal.pone.0097781
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications.
- (2015) Leonidas Platanias et al. Oncotarget
- Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin
- (2015) Silvia Cufi et al. Oncotarget
- Metformin: A Potential Therapeutic Agent for Recurrent Colon Cancer
- (2014) Pratima Nangia-Makker et al. PLoS One
- Genetic polymorphisms potentially associated with response to metformin in postmenopausal diabetics suffering and not suffering with cancer
- (2013) Lev M Berstein et al. CELL CYCLE
- Synergistic Effects of Metformin Treatment in Combination with Gefitinib, a Selective EGFR Tyrosine Kinase Inhibitor, in LKB1 Wild-type NSCLC Cell Lines
- (2013) F. Morgillo et al. CLINICAL CANCER RESEARCH
- Glucocorticoid-induced hyperglycemia is prevalent and unpredictable for patients undergoing cancer therapy: an observational cohort study
- (2013) D. Harris et al. Current Oncology
- Colon epithelial proliferation and carcinogenesis in diet-induced obesity
- (2013) Hirokazu Takahashi et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells
- (2013) Angela Kwok-Fung Lo et al. JOURNAL OF PATHOLOGY
- Aminoimidazole Carboxamide Ribonucleotide (AICAR) Inhibits the Growth of Retinoblastoma In Vivo by Decreasing Angiogenesis and Inducing Apoptosis
- (2013) Sofia Theodoropoulou et al. PLoS One
- Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review
- (2013) Monica Franciosi et al. PLoS One
- Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients
- (2013) Yanfei Zhang et al. PLoS One
- Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
- (2013) H. A. Hirsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Use of Metformin Is Not Associated with a Decreased Risk of Colorectal Cancer: A Case-Control Analysis
- (2012) M. Bodmer et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies
- (2012) Alberto M Martelli et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial
- (2012) Bernardo Bonanni et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin does not alter the risk of lung cancer: A case–control analysis
- (2012) Michael Bodmer et al. LUNG CANCER
- Cancer Risk Associated with Use of Metformin and Sulfonylurea in Type 2 Diabetes: A Meta-Analysis
- (2012) D. Soranna et al. ONCOLOGIST
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
- (2012) Hiroshi Noto et al. PLoS One
- Metformin Accelerates the Growth of BRAF V600E -Driven Melanoma by Upregulating VEGF-A
- (2012) Matthew J. Martin et al. Cancer Discovery
- Antileukemic effects of AMPK activators on BCR-ABL-expressing cells
- (2011) E. Vakana et al. BLOOD
- Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
- (2011) Meei-Shyuan Lee et al. BMC CANCER
- Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer
- (2011) Soley Bayraktar et al. CANCER
- Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types
- (2011) D. Iliopoulos et al. CANCER RESEARCH
- The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
- (2011) Jin Ha Lee et al. INTERNATIONAL JOURNAL OF CANCER
- 5-Aminoimidazole-4-carboxyamide Ribonucleoside Induces G1/S Arrest and Nanog Downregulation via p53 and Enhances Erythroid Differentiation
- (2011) Hee-Don Chae et al. STEM CELLS
- AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells
- (2010) A. F. Santidrian et al. BLOOD
- Retinoblastoma cells are inhibited by aminoimidazole carboxamide ribonucleotide (AICAR) partially through activation of AMP-dependent kinase
- (2010) Sofia Theodoropoulou et al. FASEB JOURNAL
- AMPK as a metabolic tumor suppressor: control of metabolism and cell growth
- (2010) Zhijun Luo et al. Future Oncology
- Aberrant epigenetic patterns in the etiology of gastrointestinal cancers
- (2010) Paweł Karpiński et al. JOURNAL OF APPLIED GENETICS
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Acadesine Kills Chronic Myelogenous Leukemia (CML) Cells through PKC-Dependent Induction of Autophagic Cell Death
- (2009) Guillaume Robert et al. PLoS One
- The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis
- (2009) D. Guo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Myocardial SSAT induction via AMPK signaling and its implication for ischemic injury
- (2007) Ji-Hye Ryu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now